Cedarburg Hauser Pharmaceuticals
Pioneering the path from concept to market with comprehensive development and manufacturing solutions.
Pioneering the path from concept to market with comprehensive development and manufacturing solutions.
Cedarburg Hauser Pharmaceuticals, founded in 1998, is a contract development and manufacturing organization focusing on active pharmaceutical ingredients (APIs) and intermediates. The company's slogan – "Pioneering the path from concept to market with comprehensive development and manufacturing solutions" – reflects its commitment to providing end-to-end solutions. Cedarburg Hauser Pharmaceuticals operates multiple facilities for non-GMP R&D projects, GMP kilo labs for early-phase projects, and GMP plant capacity for late-stage and commercial APIs. Leveraging its expertise in drug development, the company aims to assist clients in advancing their drug candidates from preclinical evaluations through clinical trials and ultimately to market. In 04 March 2004, the company received a significant investment of $7.00M in a Series A round, with Signet Healthcare Partners as the investors. Cedarburg Hauser Pharmaceuticals operates in the Biotechnology and Manufacturing industries with a strong focus on providing comprehensive development and manufacturing solutions for its clients.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $7.00M | 1 | Signet Healthcare Partners | 04 Mar 2004 |
No recent news or press coverage available for Cedarburg Hauser Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.